Biopharmaceutical Market Scope Rising With Escalating Health Concerns - IndustryARC
March 27, 2017 22:30 ET
|
IndustryARC
Hyderabad, India, March 27, 2017 (GLOBE NEWSWIRE) -- The report “Biopharmaceutical Market: By Source (Unicellular & Multicellular Systems) By Products (Vaccines, Enzymes, Others) Manufacturing...
Agile Therapeutics Reports First Quarter 2016 Financial Results
May 09, 2016 16:10 ET
|
Agile Therapeutics, Inc.
Cash Expected to Fund Operations through the End of 2017Clinical Trial Expected to Complete in Fourth Quarter 2016 and Resubmission Planned for First Half 2017 PRINCETON, N.J., May 09, 2016 ...
Alectos Therapeutics Announces FDA Orphan Drug Designation for MK-8719: An Investigational Small-molecule OGA Inhibitor for Treatment of Progressive Supranuclear Palsy
April 20, 2016 09:00 ET
|
Alectos Therapeutics Inc.
VANCOUVER, BRITISH COLUMBIA, April 20, 2016 (GLOBE NEWSWIRE) -- Alectos Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation...
Agile Therapeutics to Present at Women’s Health 2016: The 24th Annual Congress
April 15, 2016 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
AbCellera and Merck Sign Novel Therapeutic Antibody Discovery Collaboration
January 27, 2016 16:08 ET
|
AbCellera
VANCOUVER, British Columbia, Jan. 27, 2016 (GLOBE NEWSWIRE) -- AbCellera, a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune cells, today...
![Independence Blue Cross logo](/news-release/logo/262614/0/262614.png?lastModified=12%2F09%2F2016%2022%3A41%3A11&size=2)
Independence Blue Cross CEO Speaks at Annual Milken Institute Global Conference
April 29, 2015 10:30 ET
|
Independence Blue Cross
Daniel J. Hilferty shares insight on organization's Human-Centered InnovationSM
PHILADELPHIA, Pa., April 29, 2015 (GLOBE NEWSWIRE) -- Independence Blue Cross (Independence) President and CEO...
![Rafarma Pharmaceuticals, Inc. logo](/news-release/logo/258442/0/258442.jpg?lastModified=12%2F10%2F2016%2000%3A29%3A48&size=2)
Rafarma Pharmaceuticals (RAFA) Commences Preparation of Audited Financials
May 12, 2014 09:15 ET
|
Rafarma Pharmaceuticals, Inc.
MOSCOW, May 12, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view to...
![Pamlab LLC Logo](/news-release/logo/226867/0/226867.jpg?lastModified=12%2F09%2F2016%2023%3A57%3A33&size=2)
Pamlab LLC and Others Seek U.S. International Trade Commission Action to Block Importation of Certain Medical Food Products and Ingredients
September 12, 2012 11:49 ET
|
Pamlab LLC
WASHINGTON, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Pamlab LLC, a specialty pharmaceutical company that provides medical foods and foods for special dietary use, has joined Merck & Cie and South...
Documents Uncovered by Judicial Watch Detail Big Pharma Campaign Access to Democratic Governors During 2012 National Governors Association Meeting
March 28, 2012 14:11 ET
|
Judicial Watch
WASHINGTON, DC--(Marketwire - Mar 28, 2012) - Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has uncovered documents...
Outcomes-Based Pricing Agreements Between Pharma and Managed Care Organizations Are on the Rise, Says Cutting Edge Information
May 14, 2009 10:25 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - May 14, 2009) - The recent agreements between
Merck and Cigna, as well as Sanofi-Aventis, Procter & Gamble and Health
Alliance, signify a major shift in...